Thus, we further explored the correlation of ADAMs with the immune subtypes and observed that ADAM8, ADAM10, ADAM11, ADAM12, ADAM15, ADAM19, ADAM22, ADAM23, ADAM28, and ADAM33 were differentially expressed in both BRCA and COAD (Figure 8). This evidence concerns the gene ADAM33 and colon adenocarcinoma.